{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:28:05Z","timestamp":1789421285789,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.waojou.2022.100691","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T14:15:52Z","timestamp":1662560152000},"page":"100691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Prapasri","family":"Kulalert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phichayut","family":"Phinyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-4152","authenticated-orcid":false,"given":"Mongkol","family":"Lao-Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.waojou.2022.100691_bib1","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaci.2009.05.013","article-title":"Burden of allergic rhinitis: results from the Pediatric Allergies in America survey","volume":"124","author":"Meltzer","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100691_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","article-title":"Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC) phase three","volume":"64","author":"Ait-Khaled","year":"2009","journal-title":"Allergy"},{"issue":"Suppl 86","key":"10.1016\/j.waojou.2022.100691_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world Health organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.waojou.2022.100691_bib4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/all.13805","article-title":"2019 ARIA Care pathways for allergen immunotherapy","volume":"74","author":"Bousquet","year":"2019","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100691_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"issue":"1 Suppl","key":"10.1016\/j.waojou.2022.100691_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.waojou.2022.100691_bib7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2022.100691_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2016.04.061","article-title":"Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses","volume":"138","author":"Durham","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2022.100691_bib9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"10.1016\/j.waojou.2022.100691_bib10","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.jaip.2021.08.018","article-title":"Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison","volume":"9","author":"Kim","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2022.100691_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2015.12.1298","article-title":"Sublingual or subcutaneous immunotherapy for allergic rhinitis?","volume":"137","author":"Durham","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile","volume":"67","author":"Calderon","year":"2012","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.waojou.2022.100691_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199008233230802","article-title":"Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study","volume":"23","author":"Sporik","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.waojou.2022.100691_bib14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaip.2022.01.046","article-title":"Efficacy and safety of house dust mite sublingual immunotherapy tablet in allergic asthma: a systematic review of randomized controlled trials","volume":"10","author":"Wongsa","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100691_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/all.13583","article-title":"Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: a Meta-analysis of randomized controlled trials","volume":"74","author":"Huang","year":"2019","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.waojou.2022.100691_bib16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/all.13429","article-title":"Clinical trials in allergen immunotherapy: current concepts and future needs","volume":"73","author":"Pfaar","year":"2018","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.waojou.2022.100691_bib17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/all.12383","article-title":"Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper","volume":"69","author":"Pfaar","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2022.100691_bib18","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.waojou.2022.100691_bib19","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.waojou.2022.100691_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.waojou.2022.100691_bib21","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr Clin Trials"},{"key":"10.1016\/j.waojou.2022.100691_bib23","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"7454","key":"10.1016\/j.waojou.2022.100691_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.waojou.2022.100691_bib25","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100691_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100691_bib27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/all.12996","article-title":"House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis","volume":"72","author":"Okamoto","year":"2017","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2022.100691_bib29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaci.2016.09.043","article-title":"Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis","volume":"139","author":"Okubo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2022.100691_bib30","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/all.13544","article-title":"Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children","volume":"73","author":"Masuyama","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2022.100691_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/pai.12984","article-title":"Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: a randomized trial in a pediatric population","volume":"30","author":"Okamoto","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A\u00a0300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a world allergy organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.waojou.2022.100691_bib34","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1111\/all.14957","article-title":"Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report","volume":"76","author":"Pfaar","year":"2021","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.waojou.2022.100691_bib35","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/alr.22149","article-title":"Sublingual immunotherapy for pediatric allergic conjunctivitis: a meta-analysis of randomized controlled trials","volume":"8","author":"Yang","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.waojou.2022.100691_bib36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI subcutaneous immunotherapy surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2022.100691_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2016.02.001","article-title":"Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: national surveillance study on allergen immunotherapy (2008-2013)","volume":"116","author":"Epstein","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/all.13066","article-title":"European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a real-life clinical assessment","volume":"72","author":"Calderon","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2022.100691_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a pediatric assessment","volume":"28","author":"Rodriguez Del Rio","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100691_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaip.2016.09.017","article-title":"Current evidence on safety and practical considerations for administration of sublingual allergen immunotherapy (SLIT) in the United States","volume":"5","author":"Epstein","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.waojou.2022.100691_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.anai.2016.12.009","article-title":"Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update","volume":"118","author":"Greenhawt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2022.100691_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:46:32Z","timestamp":1761849992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455122000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1939455122000679"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100691","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100691"}}